Basic research defies traditional investment logic, yet economies reap unforeseen, high returns from its unpredictable advancements.
The Language of Investment
The term “investing in science” often misrepresents basic research, which differs fundamentally from classic financial investment. Applied research presents clearer problems, goals, and predictable paths to solutions, with firms seeking specific outcomes from scientists.
The Nature of Basic Research
Basic research thrives on exploring the unknown; its essence is pushing knowledge boundaries without guaranteed outcomes or quick monetization. As often attributed to Einstein, if we knew what we were seeking, it wouldn’t be called research. Historical breakthroughs rarely find their initially intended applications, often yielding unforeseen, more profitable uses discovered by business years later.
Economic Returns on Risk
From an economic perspective, the risk of basic research proves exceptionally profitable. Economists measure impacts using natural “experiments,” like sudden budget shifts for U.S. research institutions. Results show returns—measured via productivity growth and fiscal income—surpass those from public spending on infrastructure, schools, or hospitals. Science fuels long-term growth by attracting top talent and permeating the entire economy.
Poland’s Funding Gap
Polish science relies almost solely on public funds, which are not only limited but also highly selective, funding only 10-12% of projects (compared to ~30% in Germany and ~25% in the U.S.). In contrast, nations like Sweden, Germany, the UK, and the U.S. leverage significant private investment, enabling stable, independent research environments through company-funded institutes, chairs, and teams, leading to top-tier centers and economic impact.
While Polish business often funds scholarships, competitions, or image-building, it rarely supports mature basic research teams. The argument that only multi-generational capital nations can afford this is debunked; Ivy League universities grew from single-generation fortunes, highlighting mindset over asset tenure. Financing science mirrors supporting art—valuable for its own sake, with communal benefits enhancing donor satisfaction. Crucially, a modest 3-5 million złoty investment can build a breakthrough research team in Poland, given competitive funding, scientific independence, and stability. The only loss is in pride, agency, and future impact; patents or direct Excel returns may not materialize, but contributing to world-changing knowledge is an investment that always pays off.
